PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsEFINEPTAKIN ALFA
EFINEPTAKIN ALFA
Efineptakin alfa is a protein pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
35 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
NeoplasmsD009369—C8042——15
GlioblastomaD005909EFO_0000515—23——15
CarcinomaD002277—C80.032———4
LymphopeniaD008231—D72.81041———4
Covid-19D000086382—U07.131———4
GliomaD005910EFO_0000520—21——13
MelanomaD008545——11——12
Squamous cell carcinomaD002294——21———2
Colorectal neoplasmsD015179——21———2
Non-small-cell lung carcinomaD002289——12———2
Show 20 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Hiv infectionsD015658EFO_0000764B202————2
InfectionsD007239EFO_0000544—2————2
LymphomaD008223—C85.92————2
B-cell lymphomaD016393——2————2
Neoplasm metastasisD009362EFO_0009708—1————1
LeukopeniaD007970EFO_0004233D72.8191————1
Sars-cov-2D000086402——1————1
AlphapapillomavirusD052685——1————1
Healthy volunteers/patients———1————1
Progressive multifocal leukoencephalopathyD007968EFO_0007455A81.21————1
Show 6 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Cervical intraepithelial neoplasia——D06————11
Uterine cervical dysplasiaD002578EFO_1000910N87————11
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameEFINEPTAKIN ALFA
INNefineptakin alfa
Description
Efineptakin alfa is a protein pharmaceutical. It is currently being investigated in clinical studies.
Classification
Protein
Drug classFc fusion protein; interleukins: interleukin-7 analogues and derivatives
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID—
RxCUI—
ChEMBL IDCHEMBL4594590
ChEBI ID—
PubChem CID—
DrugBank—
UNII ID3K3WC6MT6P (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 67 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
22 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use